Literature DB >> 27398144

miR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma.

Songyang Liu1, Kai Liu1, Wei Zhang1, Yingchao Wang1, Zhe Jin1, Baoxing Jia1, Yahui Liu1.   

Abstract

MicroRNAs (miRNAs) are a class of small, non-coding RNAs that play a crucial role in tumor procession. It has been demonstrated that miR-449a expression was downregulated and served as tumor suppressor in many types of tumor. However, the biological function and molecular mechanism of miR-449a in hepatocellular carcinoma (HCC) still remains largely unknown. Therefore, the aims of this study were to investigate biological role and molecular mechanism of miR-449a in HCC by a serial of molecular experiments. Here, we demonstrated that miR-449a expression was downregulated in HCC tissues and cell lines compared with the adjacent nontumor tissues and normal hepatic cell line. Ectopic expression of miR-449a suppressed HCC cell proliferation, colony formation, migration and invasion. Moreover, A Disintegrin And Metalloproteinases 10 (ADAM10) was identified as a direct target gene of miR-449a in HCC cell. ADAM10 expression was upregulated in HCC tissues and cell lines, and was negatively correlated with the expression level of miR-449a in HCC tissues. Interesting, overexpression of ADAM10 attenuated the inhibition effect of miR-449a-mediated HCC cell proliferation, colony formation, migration and invasion. These results suggested that miR-449a might function as a tumor suppressor miRNA, at least in part, through regulating ADAM10 expression in HCC.

Entities:  

Keywords:  ADAM10; Hepatocellular carcinoma; invasion; miR-449a; proliferation

Year:  2016        PMID: 27398144      PMCID: PMC4931155     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  31 in total

Review 1.  Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure.

Authors:  Theo Klein; Rainer Bischoff
Journal:  J Proteome Res       Date:  2010-10-14       Impact factor: 4.466

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 3.  ADAMs in cancer cell proliferation and progression.

Authors:  Satsuki Mochizuki; Yasunori Okada
Journal:  Cancer Sci       Date:  2007-03-09       Impact factor: 6.716

Review 4.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

5.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

6.  MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.

Authors:  Jiacong You; Yalong Zhang; Yang Li; Nianzhen Fang; Bin Liu; Lingling Zu; Qinghua Zhou
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

Review 7.  MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

Authors:  Silvia Giordano; Amedeo Columbano
Journal:  Hepatology       Date:  2012-12-26       Impact factor: 17.425

8.  miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1.

Authors:  Yonglei Liu; Yutong Wang; Xiangjun Sun; Chuanzhong Mei; Liying Wang; Zengxia Li; Xiliang Zha
Journal:  Oncotarget       Date:  2016-03-22

9.  Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.

Authors:  Parameet Kumar; Shashwat Sharad; Gyorgy Petrovics; Ahmed Mohamed; Albert Dobi; Taduru L Sreenath; Shiv Srivastava; Roopa Biswas
Journal:  Oncotarget       Date:  2016-04-19

10.  MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.

Authors:  Yilong Yao; Jun Ma; Yixue Xue; Ping Wang; Zhen Li; Zhiqing Li; Yi Hu; Xiuli Shang; Yunhui Liu
Journal:  Mol Oncol       Date:  2014-11-20       Impact factor: 6.603

View more
  12 in total

1.  Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.

Authors:  Rui Zhang; Li-Jie Zhang; Mei-Ling Yang; Lan-Shan Huang; Gang Chen; Zhen-Bo Feng
Journal:  Mol Med Rep       Date:  2017-11-27       Impact factor: 2.952

Review 2.  New Insights into the Epigenetics of Hepatocellular Carcinoma.

Authors:  Braira Wahid; Amjad Ali; Shazia Rafique; Muhammad Idrees
Journal:  Biomed Res Int       Date:  2017-03-19       Impact factor: 3.411

Review 3.  Stage-dependent involvement of ADAM10 and its significance in epileptic seizures.

Authors:  Xu Zhou; Hua Tao; Yujie Cai; Lili Cui; Bin Zhao; Keshen Li
Journal:  J Cell Mol Med       Date:  2019-05-13       Impact factor: 5.310

4.  The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors.

Authors:  Eduardo Tormo; Sandra Ballester; Anna Adam-Artigues; Octavio Burgués; Elisa Alonso; Begoña Bermejo; Silvia Menéndez; Sandra Zazo; Juan Madoz-Gúrpide; Ana Rovira; Joan Albanell; Federico Rojo; Ana Lluch; Pilar Eroles
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

5.  miR-449a regulates insulin signalling by targeting the Notch ligand, Jag1 in skeletal muscle cells.

Authors:  Shagun Poddar; Devesh Kesharwani; Malabika Datta
Journal:  Cell Commun Signal       Date:  2019-07-25       Impact factor: 5.712

6.  MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10.

Authors:  Haining Meng; Qiao Huang; Xijin Zhang; Jiawei Huang; Ruowu Shen; Bei Zhang
Journal:  Onco Targets Ther       Date:  2019-05-16       Impact factor: 4.147

7.  miR-449a Is Related to Short-Term Recurrence of Hepatocellular Carcinoma and Inhibits Migration and Invasion by Targeting Notch1.

Authors:  Bing Han; Jiawei Huang; Zhenjie Yang; Jiaqi Zhang; Xiaomin Wang; Ning Xu; Haining Meng; Junyu Wu; Qiao Huang; Xi Yang; Ruowu Shen; Chuandong Sun
Journal:  Onco Targets Ther       Date:  2019-12-13       Impact factor: 4.147

8.  miR-449a Suppresses Tumor Growth, Migration, and Invasion in Non-Small Cell Lung Cancer by Targeting a HMGB1-Mediated NF-κB Signaling Pathway.

Authors:  Dandan Wu; Jun Liu; Jianliang Chen; Haiyan He; Hang Ma; Xuedong Lv
Journal:  Oncol Res       Date:  2018-03-21       Impact factor: 5.574

9.  Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis.

Authors:  Xia Yang; Han-Lin Wang; Hai-Wei Liang; Liang Liang; Dong-Yue Wen; Rui Zhang; Gang Chen; Dan-Ming Wei
Journal:  Exp Ther Med       Date:  2018-02-05       Impact factor: 2.447

10.  Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10.

Authors:  Kaku Goto; Jun Arai; Anthony Stephanou; Naoya Kato
Journal:  Oncotarget       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.